Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
close this folder1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents1.1 Parasitic Diseases
View the document1.2 Bacillary Dysentery
Open this folder and view contents1.3 Diarrhoea
Open this folder and view contents1.4 Cholera
close this folder1.5 Ulcers and related conditions
View the document1.5.1 Peptic Ulcer-General Measures
View the document1.5.2 Oesophageal Ulcer
View the document1.5.3 Gastric Ulcer
View the document1.5.4 Duodenal Ulcer
View the document1.5.5 Non-Ulcer Dyspepsia
View the document1.5.6 Acute Gastritis
View the document1.5.7 Gastro-Enteritis (Food Poisoning Viral)
View the document1.5.8 Ulcerative colitis
Open this folder and view contents1.6 Other gastro-intestinal problems
Open this folder and view contents1.7 Liver Diseases Conditions
Open this folder and view contents2. RESPIRATORY DISEASES
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents4. CARDIOVASCULAR DISEASES
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
Open this folder and view contents12. TUBERCULOSIS AND LEPROSY
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 
1.5.8 Ulcerative colitis

Clinical features: Ulcerative colitis is a chronic condition of unknown cause in which there are changes in the structure of the mucosa and submucosa of the wall of the colon, with widespread inflammation and superficial ulceration. Symptoms vary from diarrhoea in mild cases to septicaemia, dehydration and malnutrition in severe forms. Diarrhoea, with blood and mucus in the faeces, is a common sign, although the disease is confined to the rectum there may be paradoxically constipation.

Treatment guidelines

• Refer to specialist.
• Localized disease - treat with topical steroids:

Prednisalone (enema) 20 mg at night; or same dose via rectal catheter.


CAUTION Give steroids only in confirmed cases of U.C. Exclusion of infective colitises (especially amoebic) is vital; a therapeutic trial of metronidazole should be given.

Widespread colitis:

Sulphasalazine (O) 1 gram four times a day for acute disease, reducing to 500 mg four times a day for maintenance (caution in G6PD deficiency)

Plus


Prednisolone (O) 30-60 mg once daily for severe acute and extensive disease; reduce gradually according to disease severity.

Sulphasalazine (O)


Children over 2 years. Acute attack

40 - 60 mg/kg body weight daily

Maintenance dose

20 - 30 mg/kg body weight daily.

NOTE Life long follow up is required.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French